Loading…
NOCIL (NOCIL)₹138.05−0.98%Specialty Chemicals
NOCIL is compared with the 10 closest in size in Specialty Chemicals (135 companies in the industry). It has a P/E of 29.8 against a peer median of 22.8, and ROCE of 4.0% against a peer median of 8.0%, and latest-quarter sales growth of 32.9% against a peer median of 19.0%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Specialty Chemicals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Epigral | 3,837 | 14.2 | 15.0 | 16.1 | 0.26 | 0.6 | 2,517 | 331 | 16.2 | −38.0 | vs NOCIL |
| Vishnu Chemicals | 3,789 | 25.3 | 16.1 | 14.4 | 0.49 | 0.1 | 1,612 | 141 | 24.7 | 25.0 | vs NOCIL |
| Chemplast Sanmar | 3,758 | — | 0.0 | −6.8 | 1.12 | 0.0 | 4,218 | −281 | 2.3 | — | vs NOCIL |
| Styrenix Performance Materials | 3,272 | 13.0 | 14.0 | 14.1 | 0.40 | 2.5 | 3,428 | 183 | 24.3 | −48.9 | vs NOCIL |
| Ddev Plastiks Industries | 2,599 | 12.8 | 31.0 | 21.9 | 0.06 | 0.7 | 2,944 | 203 | 3.9 | 5.8 | vs NOCIL |
| Rossari Biotech | 2,354 | 15.4 | 13.0 | 10.8 | 0.28 | 0.1 | 2,390 | 149 | 19.0 | 5.3 | vs NOCIL |
| NOCIL | 2,305 | 29.8 | 4.0 | 2.6 | 0.00 | 1.1 | 1,301 | 56 | 32.9 | 100.1 | — |
| S H Kelkar and Company | 1,800 | 20.4 | 6.0 | 3.7 | 0.75 | 0.8 | 2,368 | 69 | 14.1 | 73.1 | vs NOCIL |
| Oriental Aromatics | 1,659 | 305.7 | 4.0 | 0.5 | 0.61 | 0.1 | 1,031 | 3 | 15.2 | 410.2 | vs NOCIL |
| Paushak | 1,513 | 35.7 | 8.0 | 7.0 | 0.16 | 0.4 | 219 | 39 | 50.0 | 25.0 | vs NOCIL |
| Camlin Fine Sciences | 1,502 | 253.3 | 5.0 | 3.8 | 0.69 | 0.0 | 1,721 | 24 | 27.5 | — | vs NOCIL |
| Peer median | 2,354 | 22.8 | 8.0 | 7.0 | 0.40 | 0.4 | 2,368 | 69 | 19.0 | 25.0 |
Listed companies closest to NOCIL in Specialty Chemicals include Epigral, Vishnu Chemicals, Chemplast Sanmar, Styrenix Performance Materials, Ddev Plastiks Industries, Rossari Biotech, S H Kelkar and Company, Oriental Aromatics.
Epigral, with a market cap of ₹3,837 Cr.
NOCIL trades at a P/E of 29.8; the median of its peer set is 22.8. A P/E above or below the median is a description, not a judgement on value.
NOCIL's return on capital employed is 4.0%, below the peer median of 8.0%.